IL-1β drives inflammatory responses to propionibacterium acnes in vitro and in vivo

Journal of Investigative Dermatology

Volumn 134, Issue 3, 2014, Pages 677-685

  Kistowska, Magdalena ^a   Gehrke, Samuel ^a   Jankovic, Dragana ^a   Kerl, Katrin ^a   Fettelschoss, Antonia ^a   Feldmeyer, Laurence ^a   Fenini, Gabriele ^a   Kolios, Antonios ^a   Navarini, Alexander ^a   Ganceviciene, Ruta ^b   Schauber, Jürgen ^c   Contassot, Emmanuel ^a   French, Lars E ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b VILNIUS UNIVERSITY   (Lithuania)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACNE VULGARIS; ANIMALS; CARRIER PROTEINS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INFLAMMASOMES; INTERLEUKIN-1BETA; KERATINOCYTES; LEUKEMIA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MONOCYTES; PHAGOCYTOSIS; PROPIONIBACTERIUM ACNES; RNA, SMALL INTERFERING;

CRYOPYRIN; INFLAMMASOME; INTERLEUKIN 1BETA; MESSENGER RNA; POTASSIUM; REACTIVE OXYGEN METABOLITE;

ACNE; ARTICLE; BONE MARROW CELL; COMMENSALISM; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INNATE IMMUNITY; LYSOSOME; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PHAGOCYTOSIS; POTASSIUM TRANSPORT; PROPIONIBACTERIUM ACNES;

EID: 84894041097     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2013.438     Document Type: Article

References (49)

1. Bojar RA, Holland KT (2004) Acne and Propionibacterium acnes. Clin Dermatol 22:375-99
2. Braun-Falco M, Kovnerystyy O, Lohse P et al. (2012) Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)-A new autoinflammatory syndrome distinct from PAPA syndrome. J Am Acad Dermatol 66:409-155
3. Brenner M, Ruzicka T, Plewig G et al. (2009) Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra. Br J Dermatol 161:1199-2011
4. Cruz CM, Rinna A, Forman HJ et al. (2007) ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages. J Biol Chem 282:2871-99
5. Degitz K, Placzek M, Borelli C et al. (2007) Pathophysiology of acne. J Dtsch Dermatol Ges 5:316-233
6. Dinarello CA (1996) Biologic basis for interleukin-1 in disease. Blood 87:2095-1477
7. Dostert C, Petrilli V, Van Bruggen R et al. (2008) Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320:674-77
8. Duncan JA, Gao X, Huang MT et al. (2009) Neisseria gonorrhoeae activates the proteinase cathepsin B to mediate the signaling activities of the NLRP33 and ASC-containing inflammasome. J Immunol 182:6460-99
9. Fay AJ, Qian X, Jan YN et al. (2006) SK channels mediate NADPH oxidaseindependent reactive oxygen species production and apoptosis in granulocytes. Proc Natl Acad Sci USA 103:17548-533
10. Feldmeyer L, Keller M, Niklaus G et al. (2007) The inflammasome mediates UVB-induced activation and secretion of interleukin-1beta by keratinocytes. Curr Biol 17:1140-55
11. Feldmeyer L, Werner S, French LE et al. (2010) Interleukin-1, inflammasomes and the skin. Eur J Cell Biol 89:638-444
12. Fitz-Gibbon S, Tomida S, Chiu BH et al. (2013) Propionibacterium acnes strain populations in the human skin microbiome associated with acne. J Invest Dermatol 133:2152-600
13. Franchi L, Amer A, Body-Malapel M et al. (2006) Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonellainfected macrophages. Nat Immunol 7:576-822
14. Glaccum MB, Stocking KL, Charrier K et al. (1997) Phenotypic and functional characterization of mice that lack the type I receptor for IL-1. J Immunol 159:3364-711
15. Gollnick H (2003) Current concepts of the pathogenesis of acne: implications for drug treatment. Drugs 63:1579-966
16. He X, Mekasha S, Mavrogiorgos N et al. (2010) Inflammation and fibrosis during Chlamydia pneumoniae infection is regulated by IL-1 and the NLRP3/ASC inflammasome. J Immunol 184:5743-544
17. Hornung V, Bauernfeind F, Halle A et al. (2008) Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 9:847-566
18. Huang MT, Taxman DJ, Holley-Guthrie EA et al. (2009) Critical role of apoptotic speck protein containing a caspase recruitment domain (ASC) and NLRP3 in causing necrosis and ASC speck formation induced by Porphyromonas gingivalis in human cells. J Immunol 182:2395-4044
19. James WD (2005) Clinical practice. Acne. N Engl J Med 352:1463-722
20. Jeremy AH, Holland DB, Roberts SG et al. (2003) Inflammatory events are involved in acne lesion initiation. J Invest Dermatol 121:20-77
21. Keller M, Sollberger G, Beer HD (2009) Thalidomide inhibits activation of caspase-1. J Immunol 183:5593-99
22. Kurokawa I, Danby FW, Ju Q et al. (2009) New developments in our understanding of acne pathogenesis and treatment. Exp Dermatol 18:821-322
23. Layton AM, Morris C, Cunliffe WJ et al. (1998) Immunohistochemical investigation of evolving inflammation in lesions of acne vulgaris. Exp Dermatol 7:191-77
24. Leeming JP, Holland KT, Cuncliffe WJ (1988) The microbial colonization of inflamed acne vulgaris lesions. Br J Dermatol 118:203-88
25. Leyden JJ, McGinley KJ, Vowels B (1998) Propionibacterium acnes colonization in acne and nonacne. Dermatology 196:55-88
26. Li P, Allen H, Banerjee S et al. (1995) Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. Cell 80:401-111
27. Mariathasan S, Newton K, Monack DM et al. (2004) Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430:213-88
28. Martinon F, Burns K, Tschopp J (2002) The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 10:417-266
29. Martinon F, Mayor A, Tschopp J (2009) The inflammasomes: guardians of the body. Annu Rev Immunol 27:229-655
30. Martinon F, Petrilli V, Mayor A et al. (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440:237-411
31. Meng G, Zhang F, Fuss I et al. (2009) A mutation in the Nlrp3 gene causing inflammasome hyperactivation potentiates Th17 cell-dominant immune responses. Immunity 30:860-744
32. Mishra BB, Moura-Alves P, Sonawane A et al. (2010) Mycobacterium tuberculosis protein ESAT-6 is a potent activator of the NLRP3/ASC inflammasome. Cell Microbiol 12:1046-633
33. Muruve DA, Petrilli V, Zaiss AK et al. (2008) The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 452:103-77
34. Nakatsuji T, Tang DC, Zhang L et al. (2011) Propionibacterium acnes CAMP factor and host acid sphingomyelinase contribute to bacterial virulence: potential targets for inflammatory acne treatment. PLoS One 6:e147977
35. Petrilli V, Papin S, Dostert C et al. (2007) Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ 14:1583-99
36. Qin M, Pirouz A, Kim MH et al. (2013) Propionibacterium acnes induces IL-1b secretion via the NLRP3 inflammasome in human monocytes. J Invest Dermatol; e-pub ahead of print 24 October 20133
37. Solle M, Labasi J, Perregaux DG et al. (2001) Altered cytokine production in mice lacking P2X(7) receptors. J Biol Chem 276:125-322
38. Strowig T, Henao-Mejia J, Elinav E et al. (2012) Inflammasomes in health and disease. Nature 481:278-866
39. Stutz A, Golenbock DT, Latz E (2009) Inflammasomes: too big to miss. J Clin Invest 119:3502-111
40. Sutterwala FS, Flavell RA (2009) NLRC4/IPAF: a CARD carrying member of the NLR family. Clin Immunol 130:2-66
41. Toyoda M, Morohashi M (2001) Pathogenesis of acne. Med Electron Microsc 34:29-400
42. Vowels BR, Yang S, Leyden JJ (1995) Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: implications for chronic inflammatory acne. Infect Immun 63:3158-655
43. Watanabe H, Gaide O, Petrilli V et al. (2007) Activation of the IL-1betaprocessing inflammasome is involved in contact hypersensitivity. J Invest Dermatol 127:1956-633
44. Watanabe H, Gehrke S, Contassot E et al. (2008) Danger signaling through the inflammasome acts as a master switch between tolerance and sensitization. J Immunol 180:5826-322
45. Wendling D, Prati C, Aubin F (2012) Anakinra treatment of SAPHO syndrome: short-term results of an open study. Ann Rheum Dis 71:1098-1000
46. Williams HC, Dellavalle RP, Garner S (2012) Acne vulgaris. Lancet 379: 361-722
47. Willingham SB, Allen IC, Bergstralh DT et al. (2009) NLRP3 (NALP3, Cryopyrin) facilitates in vivo caspase-1 activation, necrosis, and HMGB11 release via inflammasome-dependent and -independent pathways. J Immunol 183:2008-155
48. Yu JW, Fernandes-Alnemri T, Datta P et al. (2007) Pyrin activates the ASC pyroptosome in response to engagement by autoinflammatory PSTPIP11 mutants. Mol Cell 28:214-277
49. Zouboulis CC, Eady A, Philpott M et al. (2005) What is the pathogenesis of acne? Exp Dermatol 14:143-522